The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

FYI: new study results

nancy591
nancy591 CSN Member Posts: 1,027 Member
edited March 2014 in Ovarian Cancer #1
I read something interesting on the ovariancancer.org website. Largest recurrent ovarian study Phase 3 clinical trial results for recurrent ovarian with at least 6 month remission show carbo/doxil combo is superior to carbo/taxol to treat recurrence. You can read about at: ovariancancer.org
Like Care

Comments

Discussion Boards